Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen to Manufacture, Distribute CombiMatrix CustomArrays in Korea

NEW YORK, June 27 (GenomeWeb News) - CombiMatrix said today that it has entered into a manufacturing and distribution agreement with Korean biotechnology firm Macrogen.

 

Specifically, Macrogen will use CombiMatrix CustomArray Synthesizers to develop and sell CustomArrays into Korea, and to offer other services based on the arrays, CombiMatrix said.

 

Seoul-based Macrogen's core businesses include DNA sequence analysis, biochip manufacture and research, and production of genetically engineered mice. It is also one of 11 worldwide members of Applied Biosystems' Advanced Gene Expression Service Provider Program.

 

CombiMatrix said that the deal underscores its strategy of establishing manufacturing and distribution relationships with regional companies to enable them to manufacture arrays onsite for their local markets.

 

Financial details were not disclosed.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.